Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 497 of 6351
-
Liver cancer trial adds a resistance-blocker to standard chemo – could it boost success?
Disease control Recruiting nowIMPACT-TACE is an investigator-initiated, prospective, multicenter, randomized, double-blinded, interventional trial to test the hypothesis that the simultaneous application of doxorubicin with the ABCB1 inhibitor nicardipine would significantly improve the success rate of TACE t…
Phase 2/3 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New imaging tool aims to free Long-Term ventilator patients faster
Disease control Recruiting nowPatients with prolonged mechanical ventilation (PMV) frequently experience impaired ventilation distribution, respiratory muscle dysfunction, secretion retention, and delayed liberation from mechanical ventilation. Electrical impedance tomography (EIT) provides real-time bedside …
Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New eye drug could cut injection frequency for Diabetes-Related vision loss
Disease control OngoingThis is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
Phase 3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
A new care pathway aims to get cancer surgery patients home safer and faster
Disease control Recruiting nowThe goal of this randomized controlled clinical trial is to evaluate whether the Ready for Safe Cancer Treatment (RESET) program improves perioperative care and supports safe hospital discharge in two surgical populations: adult patients undergoing planned oncological surgery and…
Sponsor: Regional Specialist Hospital in Wroclaw • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New CAR-T therapy targets two proteins to fight tough leukemia and lymphoma
Disease control Not yet recruitingThe purpose of this clinical trial is to evaluate the safety and efficacy of CAR1922T2 T-cell therapy in participants with relapsed/refractory B-cell acute lymphoblastic leukemia and non-Hodgkin's lymphoma. Participants will receive a single infusion of CAR1922T2 T-cells and comp…
Early phase 1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New combo therapy aims to shrink esophageal tumors before surgery
Disease control Not yet recruitingThis study includes patients with resectable esophageal squamous cell carcinoma who will undergo local radiotherapy (PTV: 1.5Gy Bid, for 5 days), followed by neoadjuvant treatment with Serplulimab combined with cisplatin and paclitaxel for three cycles. Afterward, they will under…
Phase 2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New pill aims to stop rare lymphoma from coming back
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, phase III clinical study comprising two arms: a golidocitinib group and a placebo group. The study aimed to evaluate the antitumor efficacy and safety of golidocitinib in patients who had achieved a response after first-line system…
Phase 3 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could 4 months of antiviral drugs be enough for CMV-Infected newborns?
Disease control Not yet recruitingTitle: Evaluation of Long-term Efficacy of 4-month versus 6-month Course Antiviral Therapy for Neurodevelopmental Impairment Caused by Congenital CMV Infection: A Multicenter, Randomized, Controlled, Non-inferiority Clinical Study 1\. Background and Rationale:Congenital cytomega…
Phase 4 • Sponsor: Hu Bofei • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New Low-Cost radiation therapy could make liver cancer treatment accessible for all
Disease control Not yet recruitingPrimary liver tumors, with hepatocellular carcinoma (HCC) accounting for 80%, represent 6% of global cancer incidence and 9% of global cancer-associated mortality.HCC remains the leading causes of cancer-related deaths worldwide, due to late diagnosis. Although local-stage liver …
Phase 1 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New weekly shot shows promise for major weight loss in obesity trial
Disease control Recruiting nowPhase 2, multicenter, randomized, double-blind, placebo-controlled study evaluating once-weekly subcutaneous retatrutide (LY3437943) at multiple maintenance dose levels versus placebo in adults with obesity or overweight with weight-related comorbidities (without type 2 diabetes)…
Phase 2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
AI eye check could save your sight: new trial tests smart screening for diabetes patients
Diagnosis By invitation onlyThis pragmatic clinical trial is being conducted to test the effectiveness of AI in improving screening and follow-up eye care compared to usual-care among patients with diabetes across 4 primary care clinics. This is an autonomous AI-based screening to detect diabetic eye diseas…
Sponsor: University of Wisconsin, Madison • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC
-
Less fluid, fewer complications? trial tests new strategy in liver transplants
Disease control Recruiting nowThe goal of the REFIL-2 study is to evaluate the effectiveness of a low splanchnic blood volume restrictive fluid management strategy (a strategy that involves limiting fluid administration and prioritizing the use of medications that raise blood pressure during surgery, combined…
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Gut microbes may hold clues to sepsis organ injury
Knowledge-focused Recruiting nowSepsis is a major cause of morbidity and mortality in intensive care units. Sepsis-associated liver injury (SALI) and sepsis-associated acute kidney injury (S-AKI) are common complications associated with adverse clinical outcomes. Altered gut microbial diversity, microbial metab…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Could targeted exercises rebuild strength after Guillain-Barré?
Symptom relief CompletedThis randomized controlled trial will evaluate the effectiveness of proprioceptive neuromuscular facilitation combined with core strengthening exercises in Guillain barre syndrome patients on balance, strength and ADLS. A total of 32 participants will be recruited using purposive…
Sponsor: Rida • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can playful therapy unlock social skills in autism?
Disease control CompletedThis randomized controlled trial evaluates the efficacy of Integrated DIR/Floortime™ in improving functional emotional development and adaptive behavior in children aged 4-12 years with Autism Spectrum Disorder (ASD). Participants are randomly assigned to either an intervention g…
Sponsor: Fatima Tabassum • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
App aims to stop depression before it starts: 9,000-person trial launched
Prevention Not yet recruitingObjective: To design, develop, and evaluate a personalized intervention for the universal prevention of depression and anxiety in the general population based on risk algorithms, ICTs, and decision support systems (DSS). Methods: A double-blind, parallel-group, randomized contro…
Sponsor: The Mediterranean Institute for the Advance of Biotechnology and Health Research • Aim: Prevention
Last updated Jun 26, 2026 18:51 UTC
-
Ancient herb ashwagandha put to the test against asthma inflammation
Disease control CompletedThis randomized, double-blind, placebo-controlled study evaluated Withania somnifera root powder as a complementary therapy in adults with moderate-to-severe persistent asthma receiving standard asthma treatment. Participants were assigned to standard treatment alone, standard tr…
Sponsor: Aligarh Muslim University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New hope for pancreatic cancer: targeted combo trial opens
Disease control Recruiting nowThis study is a Phase II clinical trial that plans to enroll 40 patients with borderline resectable pancreatic cancer harboring a KRAS G12D mutation, aiming to evaluate the efficacy of HRS-4642 in combination with Nimotuzumab and AG in borderline resectable pancreatic cancer. The…
Phase 2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug cocktail aims to shrink kidney tumors after first treatment fails
Disease control Not yet recruitingThe primary objective is to evaluate the improvement in Objective Response Rate (ORR) achieved with Iparomlimab and Tuvonralimab Injection (QL1706, an Anti-PD-1/CTLA-4 Combined Antibody) in combination with Lenvatinib or Axitinib, in patients with locally advanced or metastatic c…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could two new drugs boost chemo success in HER2-Low breast cancer?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if add SHR-A1811 and/or Adebrelimab on standard chemotherapy could further improve the pCR rate in HR+/HER2 low early stage breast cancer patients. It will also learn about the safety of these combination regimen. The main questions it …
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC